Anti-Biotic Resistance episode artwork

EPISODE · Jun 1, 2019 · 28 MIN

Anti-Biotic Resistance

from The Bottom Line · host BBC Radio 4

Antibiotic resistance is a global problem but there have been no new drugs produced since the 1980s. So who is to blame? The public's over-consumption or the current economic model for drug research and production? Evan Davis and guests discuss.GUESTSSeema Patel, Medical Director, Hospital Business, Pfizer, UK, Ireland and the NordicsLord Jim O'Neill, Chair Anti-Microbial Resistance Review (2016), Former Chief Economist, Goldman SachsProfessor Colin Garner, Co Founder and Director, Antibiotic Research UK

Episode metadata supplied by the publisher feed · Published Jun 1, 2019

Embed this episode

NOW PLAYING

Anti-Biotic Resistance

0:00 28:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Bottom Line?

This episode is 28 minutes long.

When was this The Bottom Line episode published?

This episode was published on June 1, 2019.

Can I download this The Bottom Line episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!